0001104659-13-085977.txt : 20131120 0001104659-13-085977.hdr.sgml : 20131120 20131120125415 ACCESSION NUMBER: 0001104659-13-085977 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130930 FILED AS OF DATE: 20131120 DATE AS OF CHANGE: 20131120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ophthotech Corp. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 VAUGHN DRIVE STREET 2: SUITE 106 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-945-6050 MAIL ADDRESS: STREET 1: 5 VAUGHN DRIVE STREET 2: SUITE 106 CITY: PRINCETON STATE: NJ ZIP: 08540 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALAKATOS NICHOLAS CENTRAL INDEX KEY: 0001252522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 131232329 MAIL ADDRESS: STREET 1: THE JOHN HANCOCK TOWER STREET 2: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 a4.xml 4 X0306 4 2013-09-30 0 0001410939 Ophthotech Corp. OPHT 0001252522 GALAKATOS NICHOLAS C/O CLARUS VENTURES, LLC, 101 MAIN STREET, SUITE 1210 CAMBRIDGE MA 02142 1 0 1 0 Common Stock 2013-09-30 4 P 0 2500 22 A 2500 D Common Stock 2013-09-30 4 P 0 2500 22 A 2500 I See Footnote Common Stock 3054744 I See Footnote These shares are held by AAG Peakham Trust LLC. Dr. Galakatos is a manager of AAG Peakham Trust LLC. Reflects 3,054,744 shares of Common Stock held of record by Clarus Lifesciences II, L.P. ("Clarus"). Clarus Ventures II GP, L.P. (the "GPLP"), as the sole general partner of Clarus, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLP disclaims beneficial ownership of all shares held of record by Clarus in which the GPLP does not have an actual pecuniary interest. Clarus Ventures II, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLLC disclaims beneficial ownership of all shares held of record by Clarus in which the GPLLC does not have an actual pecuniary interest. Dr. Galakatos, together with other individuals identified in filings made by Clarus, each as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Clarus. Dr. Galakatos disclaims beneficial ownership of all shares held of record by Clarus in which he does not have an actual pecuniary interest. The 3,054,744 shares of Common Stock held of record by Clarus constitute shares of Common Stock issued upon the conversion of preferred stock, including shares of preferred stock issued as accrued stock dividends, in connection with the closing of the issuer's initial public offering, which shares were previously reported on a Form 4 filed on October 2, 2013. /s/ Nicholas Galakatos 2013-11-20